Trexo Robotics Inc.

Trexo Robotics Inc. specializes in programmable ambulation exoskeletons, which are wearable robotic devices designed to assist patients with walking and mobility. These exoskeletons are available for both clinical (hospital or therapy center) and home-use settings. Additionally, the company produces mechanical treadmills, which are commonly used in rehabilitation and physical therapy to aid recovery and improve mobility through controlled movement.

Trexo Robotics Inc. is headquartered in Canada. The company’s location influences its regulatory compliance, as it must adhere to both Canadian and international standards when developing and distributing its devices.

Trexo Robotics Inc.’s devices are listed in the FDA’s Unique Device Identifier (UDI) database. This registry helps track and identify medical devices in the United States, ensuring transparency and traceability for regulatory and clinical purposes.

Trexo Robotics Inc.’s devices fall under FDA’s Class I and Class II classifications. Class I devices generally pose the lowest risk and often require general controls for regulation, while Class II devices involve moderate risk and may require special controls to ensure safety and effectiveness. The classification depends on factors like the device’s intended use, potential risks, and benefits.